We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
-5.07%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$4.94B
AUM Growth
-$256M
Cap. Flow
+$155M
Cap. Flow %
3.13%
Top 10 Hldgs %
23%
Holding
310
New
46
Increased
109
Reduced
88
Closed
39

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$52.6M
2
UNH icon
UnitedHealth
UNH
+$48.5M
3
LLY icon
Eli Lilly
LLY
+$40.2M
4
BAC icon
Bank of America
BAC
+$33.6M
5
PFE icon
Pfizer
PFE
+$32.9M

Top Sells

Rank Stock Value
1
TWX
Time Warner Inc
TWX
+$55.2M
2
TMO icon
Thermo Fisher Scientific
TMO
+$45M
3
ZBH icon
Zimmer Biomet
ZBH
+$35.5M
4
COO icon
Cooper Companies
COO
+$35.5M
5
ROP icon
Roper Technologies
ROP
+$31.5M

Sector Composition

Rank Sector Weight
1 Healthcare 25.89%
2 Technology 24.22%
3 Financials 21.01%
4 Communication Services 9.7%
5 Consumer Discretionary 6.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PGR icon
151
Progressive
PGR
$125B
$9.24M 0.19%
301,500
– –
RLI icon
152
RLI Corp
RLI
$5.88B
$8.83M 0.18%
330,000
– –
ESPR
153
DELISTED
Esperion Therapeutics
ESPR
$7.3M 0.15%
309,456
-13,932
-4% -$874K
MEOH icon
154
Methanex
MEOH
$4.19B
$7.3M 0.15%
220,051
-286,359
-57% -$12.3M
GLOB icon
155
Globant
GLOB
$1.41B
$7.17M 0.15%
+234,546
New +$7.23M
CGNX icon
156
Cognex
CGNX
$10.2B
$6.95M 0.14%
404,154
-21,524
-5% -$428K
INGN icon
157
Inogen
INGN
$171M
$6.62M 0.13%
+136,300
New +$6.47M
BX icon
158
Blackstone
BX
$106B
$6.38M 0.13%
205,185
+4,586
+2% +$166K
MNDT
159
DELISTED
Mandiant, Inc. Common Stock
MNDT
$6.3M 0.13%
+198,155
New +$8.27M
ARCC icon
160
Ares Capital
ARCC
$13.6B
$5.98M 0.12%
413,000
+20,000
+5% +$314K
TD icon
161
Toronto Dominion Bank
TD
$198B
$5.86M 0.12%
125,000
– –
ADBE icon
162
Adobe
ADBE
$94.5B
$5.83M 0.12%
70,919
-94,095
-57% -$7.63M
SLRC icon
163
SLR Investment Corp
SLRC
$705M
$5.77M 0.12%
365,000
+50,000
+16% +$881K
ADI icon
164
Analog Devices
ADI
$181B
$5.73M 0.12%
101,647
-20,011
-16% -$1.16M
MAIN icon
165
Main Street Capital
MAIN
$5B
$5.66M 0.11%
212,000
+12,500
+6% +$370K
USB icon
166
US Bancorp
USB
$98.9B
$5.56M 0.11%
135,737
– –
DFS
167
DELISTED
Discover Financial Services
DFS
$5.5M 0.11%
105,816
-3,300
-3% -$181K
TMUSP
168
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
$5.44M 0.11%
78,500
+10,000
+15% +$699K
ABT icon
169
Abbott
ABT
$182B
$5.35M 0.11%
133,000
+6,800
+5% +$321K
QCOM icon
170
Qualcomm
QCOM
$179B
$5.32M 0.11%
99,087
-35,656
-26% -$2.12M
AMGN icon
171
Amgen
AMGN
$203B
$5.3M 0.11%
38,319
+15,889
+71% +$2.5M
FRC
172
DELISTED
First Republic Bank
FRC
$5.24M 0.11%
83,548
+4,038
+5% +$253K
AVGO icon
173
Broadcom
AVGO
$1.82T
$5.13M 0.1%
+410,890
New +$5.19M
BFH icon
174
Bread Financial
BFH
$4.29B
$4.84M 0.1%
+23,440
New +$5.07M
CTSH icon
175
Cognizant
CTSH
$22.3B
$4.65M 0.09%
+74,348
New +$4.67M
5 6
7
8 9

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q3 2015 Portfolio in Review

As of Q3 2015, Polar Capital held 310 positions worth $4.94B, down 4.9% from $5.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Polar Capital deployed $155M of net new capital in Q3 2015, opening 46 new positions and adding to 109 existing holdings. Its largest new stake was Allergan plc: 171,100 shares worth $46.5M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $45M trimmed.

  • Polar Capital's largest Q3 2015 buy was Allergan plc: 171,100 shares worth $46.5M.
  • Polar Capital added most to UnitedHealth in Q3 2015, an estimated $48.5M increase.
  • Polar Capital's biggest Q3 2015 reduction was Thermo Fisher Scientific, cutting an estimated $45M.
  • Polar Capital fully exited Time Warner Inc in Q3 2015, selling an estimated $55.2M.
  • Polar Capital's ten largest holdings make up 23% of its $4.94B portfolio in Q3 2015.
  • Polar Capital opened 46 new positions and closed 39 in Q3 2015.
  • Polar Capital's portfolio value fell 4.9% quarter-over-quarter to $4.94B.

Based on Polar Capital's 13F filing for Q3 2015, filed 16 Nov 2015.